Global Molecular Diagnosis of Tumors Supply, Demand and Key Producers, 2023-2029

Global Molecular Diagnosis of Tumors Supply, Demand and Key Producers, 2023-2029

The global Molecular Diagnosis of Tumors market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Molecular Diagnosis of Tumors demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Molecular Diagnosis of Tumors, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Molecular Diagnosis of Tumors that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Molecular Diagnosis of Tumors total market, 2018-2029, (USD Million)

Global Molecular Diagnosis of Tumors total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Molecular Diagnosis of Tumors total market, key domestic companies and share, (USD Million)

Global Molecular Diagnosis of Tumors revenue by player and market share 2018-2023, (USD Million)

Global Molecular Diagnosis of Tumors total market by Type, CAGR, 2018-2029, (USD Million)

Global Molecular Diagnosis of Tumors total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Molecular Diagnosis of Tumors market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Roche Holding, Thermo Fisher Scientific, Danaher Corporation, Veracyte, TBG Diagnostics, Agilient Technologies, Illumina and Genecast, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Molecular Diagnosis of Tumors market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Molecular Diagnosis of Tumors Market, By Region:

United States

China

Europe

Japan

South Korea

ASEAN

India

Rest of World

Global Molecular Diagnosis of Tumors Market, Segmentation by Type

NGS-Based

PCR-Based

Global Molecular Diagnosis of Tumors Market, Segmentation by Application

Hospitals

Diagnostic Centers

Others

Companies Profiled:

Abbott Laboratories

Roche Holding

Thermo Fisher Scientific

Danaher Corporation

Veracyte

TBG Diagnostics

Agilient Technologies

Illumina

Genecast

Burning Rock Biotech

Key Questions Answered

1. How big is the global Molecular Diagnosis of Tumors market?

2. What is the demand of the global Molecular Diagnosis of Tumors market?

3. What is the year over year growth of the global Molecular Diagnosis of Tumors market?

4. What is the total value of the global Molecular Diagnosis of Tumors market?

5. Who are the major players in the global Molecular Diagnosis of Tumors market?

6. What are the growth factors driving the market demand?